Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call
February 23 2017 - 4:02PM
Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global
biopharmaceutical company, today announced that it will host its
fourth quarter and full year 2016 financial results teleconference
and webcast at 8:30 a.m. Eastern on Wednesday, March 8th. The press
release announcing the financial results and operating highlights
is expected to be released before the opening of capital markets
that day.
Individuals interested in accessing the live
audio webcast of the teleconference may do so at
http://www.sucampo.com/investors/events-presentations/ and should
log on 10 to 15 minutes before the teleconference begins to
download any software required. Presentation slides will be
available via the webcast link. A replay of the webcast will also
be available on Sucampo’s website for several days after the live
event. Alternatively, individuals may dial 888-636-8238 (domestic)
or 484-747-6635 (international) and use passcode 71158094. A replay
of the teleconference will be available by dialing 855-859-2056
(domestic) or 404-537-3406 (international), passcode 71158094,
approximately two hours after the teleconference concludes. The
archive of the teleconference will be available for 30 days.
About Sucampo Pharmaceuticals,
Inc.
Sucampo Pharmaceuticals, Inc. is focused on the
development and commercialization of medicines that meet major
unmet medical needs of patients worldwide. Sucampo has two marketed
products – AMITIZA, its lead product, and RESCULA – and a pipeline
of product candidates in clinical development. A global company,
Sucampo is headquartered in Rockville, Maryland, and has operations
in Japan, Switzerland and the U.K. For more information, please
visit www.sucampo.com.
The Sucampo logo and the tagline, The Science of
Innovation, are registered trademarks of Sucampo AG. AMITIZA is a
registered trademark of Sucampo AG.
Follow us on Twitter (@Sucampo_Pharma). Follow
us on LinkedIn (Sucampo Pharmaceuticals).Twitter LinkedIn
Contact:
Sucampo Pharmaceuticals, Inc.
Silvia Taylor
Senior Vice President, Investor Relations and Corporate Affairs
1-240-223-3718
staylor@sucampo.com
Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ:SCMP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ:SCMP)
Historical Stock Chart
From Apr 2023 to Apr 2024